Biotech RadarJobs updated

COMPANY

Optimeos Life Sciences, Inc.

HQ: Princeton, NJ source · optimeos.com ↗

Our immune silent, non-viral gene replacement therapy is intended to provide the functional Arginosuccinate Synthetase enzyme that is deficient in Citrullinemia Type 1. We are leveraging the CINC technology to provide mRNA and DNA approaches to functionally curing this disease in both the pediatric and adult settings. From company website Source · Oct 13, 2026

Keywords: enzyme mrna cinc

Location: Princeton, NJ · source · Jun 3, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

  1. Grant Government grant — SBIR: $300,000 (annual award, as published), announced Jul 23, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
  2. Grant Government grant — SBIR: $300,000 (annual award, as published), announced Aug 19, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Feedback